Evoke Pharma EVOK
$ 5.88
2.8%
Quarterly report 2024-Q2
added 08-13-2024
Evoke Pharma Cash Flow 2011-2024 | EVOK
Annual Cash Flow Evoke Pharma
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-4.98 M | -6.6 M | -12.4 M | -6.63 M | -5.76 M | -6.98 M | -8.72 M | - | - | - | -3.04 M | -1.75 M | -2.89 M |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
673 K | 625 K | 295 K | 23.3 K | - | - | - | - | - | - | - | - | - |
Total Inventories |
482 K | 289 K | 186 K | 236 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Evoke Pharma
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -2.58 M | - | - | - | -1.63 M | - | -4.09 M | -2.99 M | -1.62 M | - | -10.4 M | -4.46 M | -2.95 M | - | -4.92 M | -3.11 M | -1.55 M | - | -4.61 M | -3.56 M | -1.93 M | - | -5.73 M | -4.58 M | -2.82 M | - | -5.98 M | -3.78 M | - | - | - | - | - | - | - | - | - | - | - | - | -2 M | - | - | - | -446 K | - | -1.1 M | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
2 M | 1.45 M | 673 K | 1.23 M | 1.02 M | 687 K | 625 K | 675 K | 366 K | 419 K | 295 K | 222 K | 198 K | 128 K | 23.3 K | 23.3 K | 23.3 K | 23.3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
545 K | 589 K | 482 K | 505 K | 514 K | 365 K | 289 K | 220 K | 268 K | 279 K | 186 K | 225 K | 234 K | 236 K | 236 K | 236 K | 236 K | 236 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency